These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25616823)

  • 21. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M; Torella F; Antoniou GA
    Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy.
    Krishnan P; Purushothaman KR; Purushothaman M; Tarricone A; Chen S; Singla S; Purushottam B; Kini A; Sharma S; Moreno PR
    Cardiovasc Pathol; 2019; 43():107139. PubMed ID: 31437716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M; Schmidt A; Scheinert S; Banning-Eichenseer U; Ulrich M; Bausback Y; Steiner S; Scheinert D
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
    Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kounis Syndrome after Angioplasty of the Superficial Femoral Artery with Paclitaxel-Coated Balloon.
    Narroway HG; Katib N; Gomes ML; Varcoe RL; Thomas SD
    Ann Vasc Surg; 2020 Nov; 69():450.e17-450.e22. PubMed ID: 32561243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N; Schneider H
    J Endovasc Ther; 2013 Dec; 20(6):819-25. PubMed ID: 24325699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting balloons: are they the magic bullet?
    Varcoe RL
    J Endovasc Ther; 2012 Oct; 19(5):581-4. PubMed ID: 23046321
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients.
    Oz II; Serifoglu I; Bilici M; Altinbas NK; Oz EB; Akduman EI
    Vasc Endovascular Surg; 2016 Nov; 50(8):534-540. PubMed ID: 28081691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.
    Scheinert D; Schulte KL; Zeller T; Lammer J; Tepe G
    J Endovasc Ther; 2015 Feb; 22(1):14-21. PubMed ID: 25775674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-in-human experience with the sirolimus-coated balloon in ischemic peripheral arterial disease and occlusion of the common femoral artery.
    Donas KP; Bakr NA; Paripovic M
    Vascular; 2021 Feb; 29(1):150-151. PubMed ID: 32646289
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-coated balloons are replacing the need for nitinol stents in the superficial femoral artery.
    Kitrou P; Karnabatidis D; Katsanos K
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):569-77. PubMed ID: 27128105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.